Cassava Sciences, Inc. - stock earnings
SAVA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -20.9 million USD | 2.3 million USD |
| 2023Q3 | -25.7 million USD | ? USD |
| 2023Q2 | -26.4 million USD | ? USD |
| 2023Q1 | -21.6 million USD | ? USD |
| 2022Q4 | -17.3 million USD | -1800 USD |
| 2022Q3 | -19.2 million USD | ? USD |
| 2022Q2 | -18.4 million USD | ? USD |
| 2022Q1 | -17.2 million USD | ? USD |
| 2021Q4 | -14.2 million USD | -200 USD |
| 2021Q3 | -9.6 million USD | ? USD |
| 2021Q2 | -5.1 million USD | ? USD |
| 2021Q1 | -3.5 million USD | ? USD |
| 2020Q4 | -2.6 million USD | ? USD |
| 2020Q3 | -1.4 million USD | ? USD |
| 2020Q2 | -1.1 million USD | ? USD |
| 2020Q1 | -1.2 million USD | ? USD |
| 2019Q4 | -1.5 million USD | ? USD |
| 2019Q3 | -697000 USD | ? USD |
| 2019Q2 | -1.1 million USD | ? USD |
| 2019Q1 | -1.4 million USD | ? USD |
| 2018Q4 | -677000 USD | ? USD |
| 2018Q3 | -1.3 million USD | ? USD |
| 2018Q2 | -2.5 million USD | ? USD |
| 2018Q1 | -2.2 million USD | ? USD |
| 2017Q4 | -2.4 million USD | ? USD |
| 2017Q3 | -2.6 million USD | ? USD |
| 2017Q2 | -4.2 million USD | ? USD |
| 2017Q1 | -2.7 million USD | ? USD |
| 2016Q4 | -2.5 million USD | ? USD |
| 2016Q3 | -3.5 million USD | ? USD |
| 2016Q2 | -3.0 million USD | ? USD |
| 2016Q1 | -5.8 million USD | ? USD |
| 2015Q4 | -4.5 million USD | ? USD |
| 2015Q3 | -3.7 million USD | ? USD |
| 2015Q2 | -3.4 million USD | ? USD |
| 2015Q1 | -2.6 million USD | ? USD |
| 2014Q4 | -2.2 million USD | ? USD |
| 2014Q3 | -3.5 million USD | ? USD |
| 2014Q2 | -3.2 million USD | ? USD |
| 2014Q1 | -3.5 million USD | ? USD |
| 2013Q4 | 33.0 million USD | 35.2 million USD |
| 2013Q3 | -762000 USD | 2.0 million USD |
| 2013Q2 | -301000 USD | 2.0 million USD |
| 2013Q1 | -408000 USD | 2.0 million USD |
| 2012Q4 | -1.8 million USD | 2.5 million USD |
| 2012Q3 | -1.6 million USD | 2.7 million USD |
| 2012Q2 | -130000 USD | 2.7 million USD |
| 2012Q1 | 30000 USD | 3.0 million USD |
| 2011Q4 | -391000 USD | 2.7 million USD |
| 2011Q3 | -815000 USD | 2.7 million USD |
| 2011Q2 | -1.2 million USD | 2.8 million USD |
| 2011Q1 | -207000 USD | 3.2 million USD |
| 2010Q4 | -9.2 million USD | 8.0 million USD |
| 2010Q3 | -1.0 million USD | 2.9 million USD |
| 2010Q2 | -804000 USD | 2.7 million USD |
| 2010Q1 | -1.0 million USD | 3.2 million USD |
| 2009Q4 | -297000 USD | 3.7 million USD |
| 2009Q3 | -1.3 million USD | 3.8 million USD |
| 2009Q2 | -34000 USD | 6.2 million USD |
| 2009Q1 | -1.8 million USD | 6.8 million USD |
| 2008Q4 | -1.4 million USD | 8.2 million USD |
| 2008Q3 | 15.2 million USD | 30.3 million USD |
| 2008Q2 | -1.0 million USD | 10.5 million USD |
| 2008Q1 | 2.6 million USD | 14.6 million USD |
| 2007Q4 | 1.1 million USD | 14.1 million USD |
| 2007Q3 | 3.2 million USD | 15.8 million USD |
| 2007Q2 | 3.4 million USD | 14.1 million USD |
| 2007Q1 | 12.6 million USD | 22.1 million USD |
| 2006Q4 | -5.7 million USD | 6.3 million USD |
| 2006Q3 | 9.7 million USD | 18.5 million USD |
| 2006Q2 | 1.4 million USD | 13.7 million USD |
| 2006Q1 | 877000 USD | 15.3 million USD |
| 2005Q4 | -3.1 million USD | 5.1 million USD |
| 2005Q3 | -8.8 million USD | ? USD |
| 2005Q2 | -10.2 million USD | ? USD |
| 2005Q1 | -8.6 million USD | ? USD |
| 2004Q4 | -9.3 million USD | ? USD |
| 2004Q3 | -9.2 million USD | ? USD |
| 2004Q2 | -9.1 million USD | ? USD |
| 2004Q1 | -10.2 million USD | ? USD |
| 2003Q4 | -6.7 million USD | ? USD |
| 2003Q3 | -6.0 million USD | ? USD |
| 2003Q2 | -4.3 million USD | ? USD |
| 2003Q1 | -4.6 million USD | 125000 USD |
| 2002Q4 | -5.1 million USD | 114000 USD |
| 2002Q3 | -3.1 million USD | ? USD |
| 2002Q2 | -3.7 million USD | ? USD |
| 2002Q1 | -4.0 million USD | ? USD |
| 2001Q4 | -5.7 million USD | ? USD |
| 2001Q3 | -3.4 million USD | ? USD |
| 2001Q2 | -3.1 million USD | 1 USD |
| 2001Q1 | -2.9 million USD | 1 USD |
| 2000Q4 | -2.9 million USD | ? USD |
| 2000Q3 | -5.3 million USD | 1 USD |
| 2000Q2 | -3.5 million USD | 1 USD |
| 2000Q1 | -91050 USD | 1 USD |
SAVA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -97.2 million USD | ? USD |
| 2022 | -72.5 million USD | -1800 USD |
| 2021 | -31.8 million USD | ? USD |
| 2020 | -5.9 million USD | ? USD |
| 2019 | -4.2 million USD | ? USD |
| 2018 | -6.6 million USD | ? USD |
| 2017 | -11.9 million USD | ? USD |
| 2016 | -14.9 million USD | ? USD |
| 2015 | -14.1 million USD | ? USD |
| 2014 | -12.4 million USD | ? USD |
| 2013 | 31.5 million USD | 41.1 million USD |
| 2012 | -3.4 million USD | 10.9 million USD |
| 2011 | -2.6 million USD | 11.5 million USD |
| 2010 | -12.0 million USD | 16.8 million USD |
| 2009 | -3.5 million USD | 20.6 million USD |
| 2008 | 15.3 million USD | 63.7 million USD |
| 2007 | 20.3 million USD | 66.0 million USD |
| 2006 | 6.2 million USD | 53.9 million USD |
| 2005 | -30.7 million USD | 5.1 million USD |
| 2004 | -37.8 million USD | ? USD |
| 2003 | -21.6 million USD | ? USD |
| 2002 | -15.9 million USD | 114000 USD |
| 2001 | -14.3 million USD | ? USD |
| 2000 | -17.5 million USD | 1 USD |
| 1999 | -4.5 million USD | 1 USD |
SAVA
Price: $22.10
52 week price:
Earnings Per Share: -2.32 USD
P/E Ratio: -10.39
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 2.0 million
Market Capitalization: 983.8 million